Under construction – not a live service
Sign in

NCT06560346Withdrawn

Understanding the Natural History Early in the Course or Presentation of Friedreich Ataxia

Understanding the Natural History Early in the Course or Presentation of Friedreich Ataxia (EARLY-FA); Evaluating New Clinical Outcome Assessments in Children With Friedreich Ataxia to Facilitate Clinical Trial Design.

Source: ClinicalTrials.gov · Last updated 8 Jun 2025

Reason given: Lack of Funding

Brief summary (registry, in English)

Multicenter, prospective, observational natural history and outcome measure study of children and young adults with Friedreich ataxia.

Status (registry)
Withdrawn
Study type
Observational
Enrollment
0 (actual)
First submitted
15 Aug 2024
Start date
1 May 2025
Primary completion date
1 Dec 2028
Lead sponsor
Friedreich's Ataxia Research Alliance
NCT number
NCT06560346

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Diagnosis of non-FA medical or other condition that in the opinion of the investigator would interfere with the conduct and assessments of the study or be confounding and contraindication to participation.
  • Diagnosis of a medical condition that in the opinion of the investigator could be confounding and contraindication to participation

Other

  • Pregnant female participants
  • Unable to provide informed consent.
  • Family risk for FA with unknown status
  • Unable to provide informed consent

Who the study is looking for

  • Genetic diagnosis of Friedreich Ataxia
  • Ages 4-21 years at enrollment
  • Enrollment in the UNIFAI study and ability to have simultaneous visits for both UNIFAI and EARLY-FA
  • Informed consent must be obtained for all participants:
    • For underage participants, they and the parent/ legally authorized representative have to sign the informed consent form, child assent (if applicable)
    • Persons who are not legally competent require the informed consent of their legally authorized representative
  • Ages 4-21 years at enrollment
  • Matching criteria to an enrolled participant with FA (age, sex and educational status)
  • Informed consent must be obtained for all participants:
    • For underage participants, they and the parent/ legally authorized representative have to sign the informed consent form, child assent (if applicable)
    • Persons who are not legally competent require the informed consent of their legally authorized representative

Age in the registry: 4 years to 21 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (7)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Murdoch Childrens Research InstituteParkvilleAustraliaUnknown status
McGill University Health Centre - Montreal Neurological InstituteMontrealCanadaUnknown status
University Hospital Aachen, Dept. of NeurologyAachenGermanyUnknown status
Bambino Gesù Children's Hospital, Department of NeurosciencesRomaItalyUnknown status
University of Iowa Stead Family Children's HospitalIowa CityUnited StatesUnknown status
St. Jude Children's Research HospitalMemphisUnited StatesUnknown status
Children's Hospital of PhiladelphiaPhiladelphiaUnited StatesUnknown status

Are you the coordinator? Confirm the details

This page is information, not medical advice. Discuss any trial with your doctor.